News

The patent, entitled, ‘Compositions and Methods for the Treatment of Premature Ejaculation,’ will provide Israeli patent protection until March 2024, once it is issued. Apricus Bio’s male sexual

As per the collaboaration, Constellation will receive committed funding of $95m, comprising an upfront payment and research funding for a three-year collaboration period. Constellation will also be entitled

Boehringer’s discovery team will apply the drug discovery technology to explore targets that are not easily accessible by other discovery platforms. The XenoGene technology is said to use

Regorafenib is an investigational oral multi-kinase inhibitor targeting angiogenic, stromal and oncogenic kinases and is currently being evaluated in clinical trials for its potential to treat patients with

The data demonstrated that Dimebon did not achieve statistically significant results for either of the two co-primary endpoints including the Alzheimer’s Disease Assessment Scale and the Alzheimer’s Disease

In 2005, Stallergenes used iBOLT to build an online prescription tracking service that streamlined its back-office information flows. Stallergenes has now launched a new project using Magic’s technology,

Natco Pharma chief financial officer P Bhaskara Narayana said that the facility which is worth INR 910m ($17.88m) is ready. "The actual production in the dedicated multiproduction block

The safety of the products has been confirmed by Government of Duchang County in Jiangxi Province, China. Incidents of a male infant death and illness of his twin

Reteplase is a recombinant protein and the active ingredient in the medicinal product Rapilysin, used for thrombolytic treatment of myocardial infarction. Except in US and Canada, Actavis owns